GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $682,000 | -31.9% | 78,603 | -11.2% | 0.01% | -36.4% |
| Q4 2021 | $1,001,000 | -14.5% | 88,487 | -5.0% | 0.01% | 0.0% |
| Q3 2021 | $1,171,000 | +44.2% | 93,136 | -6.8% | 0.01% | +57.1% |
| Q2 2021 | $812,000 | -36.1% | 99,981 | -27.2% | 0.01% | -41.7% |
| Q1 2021 | $1,271,000 | -4.1% | 137,371 | +0.2% | 0.01% | -20.0% |
| Q4 2020 | $1,325,000 | +10.4% | 137,061 | +41.7% | 0.02% | -16.7% |
| Q3 2020 | $1,200,000 | -10.7% | 96,704 | -6.4% | 0.02% | 0.0% |
| Q2 2020 | $1,344,000 | +10.3% | 103,358 | -13.9% | 0.02% | -5.3% |
| Q1 2020 | $1,219,000 | -41.4% | 120,059 | -9.8% | 0.02% | +18.8% |
| Q4 2019 | $2,080,000 | -5.8% | 133,059 | +1.2% | 0.02% | -5.9% |
| Q3 2019 | $2,207,000 | -27.9% | 131,421 | -4.7% | 0.02% | -26.1% |
| Q2 2019 | $3,059,000 | – | 137,925 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |